Mission
A GLOBAL NONPROFIT BIOMEDICAL RESEARCH ORGANIZATION THAT DEVELOPS VACCINES AND ANTIBODIES FOR HIV, TUBERCULOSIS, AND EMERGING INFECTIOUS DISEASES.
Public Charity
INTERNATIONAL AIDS VACCINE INITIATIVE INC
INTERNATIONAL AIDS VACCINE INITIATIVE INC is a nonprofit organization categorized as Public Charity based in NEW YORK, NY. Its most recent IRS filing (2025) reports revenue of $103.4M, expenses of $107.3M, total assets of $140.6M. Imperigo tracks 43 reported grant relationships connected to this organization totaling approximately $49.4M.
EIN: 133870223
NEW YORK, NY
International Development
NTEE: Q30
Latest filing: 2025
Total Revenue$103.4M
Total Expenses$107.3M
Total Assets$140.6M
Grant Records43
Funding Total$49.4M
Filing Years2021–2025
Where $100 goes at International Aids Vaccine Initiative Inc
How International Aids Vaccine Initiative Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$88
Programs
the work itself
$12
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $88 for programs
$88
Research and development:through scientific and clinical research in africa, india, europe, and the u.S., Iavi develops vaccines and antibodies in and for the developing world and seeks to…
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GRANTS FOR SCIENTIFIC RESEARCH
$3,727,010
$796,878
HIV/ AIDS PREVENTION
$597,786
Biomedical research
$444,648
RESEARCH- SUBCONTRACT
$66,561
Showing up to 5 of 43 total records — full history available with membership.
Officers & Directors
BOARD MEMBER
Alexis M Pinto
CHIEF OPERATING OFFICER (END 3/25)
Ana Cespedes Montoya
BOARD MEMBER
Anne Martin Simonds
CHIEF FINANCIAL OFFICER
Brandon Saft
VIRAL VACC. & HEAD OF DDL
Christopher Parksass Vp
BOARD MEMBER
David Blumberg
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $103.4M | $107.3M | $140.6M |
| 2024 | $131.2M | $143.0M | $129.9M |
| 2023 | $129.7M | $132.9M | $124.2M |
| 2022 | $146.8M | $131.2M | $128.9M |
| 2021 | $126.4M | $113.2M | $107.0M |
Between 2021 and 2025, reported annual revenue declined from $126.4M to $103.4M (-18%), with total assets most recently reported at $140.6M.
Interactive year-over-year charts and full filing details available with membership.